Drug Profile
Budesonide/mesalazine suppository - Dr. Falk Pharma
Alternative Names: mesalazine/budesonide suppositoryLatest Information Update: 24 Feb 2016
Price :
$50
*
At a glance
- Originator Dr Falk Pharma
- Class Aminosalicylic acids; Anti-inflammatories; Antiallergics; Glucocorticoids; Irritable bowel syndrome therapies; Pregnenediones; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists; Lipoxygenase-cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ulcerative proctitis
Most Recent Events
- 24 Feb 2016 No recent reports on development identified - Phase-II for Ulcerative proctitis in Germany (Rectal)
- 01 Aug 2015 Dr. Falk Pharma completes a phase II trial in Ulcerative proctitis in Germany (Rectal) (NCT01966783)
- 01 Sep 2013 Phase-II clinical trials in Ulcerative proctitis in Germany (Rectal)